1
                                UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C. 20549

                                 FORM 12b-25

                         NOTIFICATION OF LATE FILING

/ / Form 10-K   / / Form 20-F   / / Form 11-K   /X/ Form 10-Q   / / Form N-SAR

(Check One):

             For Period Ended: March 31, 1996
                               ------------------
             [ ] Transition Report on Form 10-K
             [ ] Transition Report on Form 20-F
             [ ] Transition Report on Form 11-K
             [ ] Transition Report on Form 10-Q
             [ ] Transition Report on Form N-SAR
             For the Transition Period Ended:___________________________________

________________________________________________________________________________
 Read Instruction (on back page) Before Preparing Form. Please Print or Type.

   NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS
                 VERIFIED ANY INFORMATION CONTAINED HEREIN.
________________________________________________________________________________

If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:

    N/A
________________________________________________________________________________

PART I -- REGISTRANT INFORMATION

    PACE MEDICAL, INC.
________________________________________________________________________________
Full Name of Registrant


    N/A
________________________________________________________________________________
Former Name if Applicable


    391 TOTTEN POND ROAD
________________________________________________________________________________
Address of Principal Executive Office (Street and Number)


WALTHAM, MASSACHUSETTS 02154
________________________________________________________________________________
City, State and Zip Code

PART II -- RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12-b-25(b), the following
should be completed. (Check box if appropriate)

           (a)  The reasons described in reasonable detail in Part III of this
                form could not be eliminated without unreasonable effort or
                expense;  
           (b)  The subject annual report, semi-annual report, transition
  /X/           report on Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion
                thereof, will be filed on or before the fifteenth calendar day
                following the prescribed due date; or the subject quarterly
                report of transition report on Form 10-Q, or portion thereof
                will be filed on or before the fifth calendar day following the
                prescribed due date; and
           (c)  The accountant's statement or other exhibit required by Rule
                12b-25(c) has been attached if applicable.

PART III -- NARRATIVE

State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within 
the prescribed time period. (ATTACH EXTRA SHEETS IF NEEDED) 

The Registrant has experienced a temporary delay in obtaining the quarterly
results of its European subsidiary, which are needed to finalize its
consolidated financial statements.

                                              (ATTACH EXTRA SHEETS IF NEEDED) 
                                                               SEC 1344 (11-91)
   2
PART IV -- OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this
    notification.

       RALPH E. HANSON                     617                  890-5656
__________________________________   _______________       ___________________
            (Name)                     (Area Code)          (Telephone Number)


(2) Have all other periodic reports required under Section 13 or
    15(d) of the Securities Exchange Act of 1934 or Section 30 of
    the Investment Company Act of 1940 during the preceding 12
    months (or for such shorter) period that the registrant was
    required to file such reports) been filed? If answer is no,
    identify report(s)                                            /x/Yes  / /No
________________________________________________________________________________
(3) It is anticipated that any significant change in results of
    operations from the corresponding period for the last fiscal
    year will be reflected by the earnings statements to be
    included in the subject report or portion thereof?            / /Yes  /X/No

    If so, attach an explanation of the anticipated change, both narratively
    and quantitatively, and, if appropriate, state the reasons why a reasonable
    estimate of the results cannot be made.
________________________________________________________________________________

                               PACE MEDICAL, INC.
                 ______________________________________________
                 (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.

          MAY 14, 1996                       /S/ RALPH E. HANSON
Date_______________________________       By_________________________________
                                             RALPH E. HANSON, PRESIDENT

INSTRUCTION: The form may be signed by an executive officer of the registrant
or by any other duly authorized representative. The name and title of the
person signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority
to sign on behalf of the registrant shall be filed with the form.

                                  ATTENTION
________________________________________________________________________________

  INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL CRIMINAL
                       VIOLATIONS (SEE 18 U.S.C. 1001).
________________________________________________________________________________


                             GENERAL INSTRUCTIONS

1.  This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General
    Rules and Regulations under the Securities Exchange Act of 1934.

2.  One signed original and four conformed copies of this form and amendments
    thereto must be completed and filed with the Securities and Exchange
    Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the
    General Rules and Regulations under the Act. The information contained in
    or filed with the form will be made a matter of public record in the
    Commission files.

3.  A manually signed copy of the form and amendments thereto shall be filed
    with each national securities exchange on which any class of securities of
    the registrant is registered.

4.  Amendments to the notifications must also be filed on form 12b-25 but need
    not restate information that has been correctly furnished. The form shall
    be clearly identified as an amended notification.